Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855812 · ClinicalTrials.gov registry record · NA

The Efficacy of Upper Extremity Wearable Robotic Orthosis on Improving Upper Extremity Motor Function and Activities of Daily Living in Persons With Spinal Cord Injury

A NA study of SCI - Spinal Cord Injury, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04855812: Completed NA study of SCI - Spinal Cord Injury, sponsored by Kessler Foundation.

NCT04855812 is a NA study of SCI - Spinal Cord Injury that has completed, run by Kessler Foundation. The registered enrollment target is 15 participants, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855812, a NA study of SCI - Spinal Cord Injury, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

To evaluate the usefulness of an upper extremity (UE) assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury (iSCI)

Primary Outcome

Movement of upper extremity is measured using small sensors that are able to record joints' angles. These sensors are placed on participant's skin via double sticky tape. Participants will be asked to move their hand and forearm while the elbow, wrist and hand joint angles are measured.

Conditions Studied

Interventions

  • OTHER Control
  • DEVICE MyoMo
  • OTHER Myo-SB

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-10-27
Est. Completion 2023-09-30
Phase NA
Kessler Foundation

104 total trials

What the finished NCT04855812 record still lists

NCT04855812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (59% lower).

The record links to 1 condition, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT04855812 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT04855812 about?

NCT04855812 is a clinical study titled "The Efficacy of Upper Extremity Wearable Robotic Orthosis on Improving Upper Extremity Motor Function and Activities of Daily Living in Persons With Spinal Cord Injury". To evaluate the usefulness of an upper extremity (UE) assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury (iSCI)

What is the current status of trial NCT04855812?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-10-27. Estimated completion is 2023-09-30.

What conditions does trial NCT04855812 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury.

What interventions are being tested in trial NCT04855812?

The interventions under investigation include: Control (OTHER), MyoMo (DEVICE), Myo-SB (OTHER).

Who is sponsoring clinical trial NCT04855812?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855812 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04855812's enrollment target sits among peer trials

15 12th of 13 higher than 2 of 13 other SCI - Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other SCI - Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04855812, the US trial registry maintained by the National Library of Medicine. NCT04855812 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.